SE Holdings and Incubations Co., Ltd. (TYO:9478)
Japan · Delayed Price · Currency is JPY 370.00
-7.00 (-1.86%)
Aug 1, 2025, 3:30 PM JST
Verve Therapeutics Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Net Income | - | 803 | 1,127 | 1,386 | 1,389 | 872 | Upgrade |
Depreciation & Amortization | - | 55 | 51 | 55 | 61 | 53 | Upgrade |
Loss (Gain) From Sale of Assets | - | 6 | 22 | 4 | 2 | 4 | Upgrade |
Loss (Gain) From Sale of Investments | - | -5 | -37 | -7 | 22 | 15 | Upgrade |
Other Operating Activities | - | -256 | -210 | -540 | -462 | -102 | Upgrade |
Change in Accounts Receivable | - | 22 | 110 | -861 | -584 | -635 | Upgrade |
Change in Inventory | - | -84 | -79 | -18 | -53 | 66 | Upgrade |
Change in Accounts Payable | - | -139 | 56 | 22 | 37 | 33 | Upgrade |
Change in Other Net Operating Assets | - | -663 | -561 | -52 | 197 | 119 | Upgrade |
Operating Cash Flow | - | -261 | 479 | -11 | 609 | 425 | Upgrade |
Operating Cash Flow Growth | - | - | - | - | 43.29% | 53.99% | Upgrade |
Capital Expenditures | - | -44 | -20 | -11 | -11 | -52 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 32 | - | 7 | 1 | Upgrade |
Divestitures | - | - | - | - | -17 | - | Upgrade |
Sale (Purchase) of Intangibles | - | -27 | -35 | -17 | -30 | -20 | Upgrade |
Investment in Securities | - | 53 | 63 | 24 | -10 | -5 | Upgrade |
Other Investing Activities | - | 1 | 4 | 1 | 8 | -2 | Upgrade |
Investing Cash Flow | - | -16 | 45 | -2 | -53 | -78 | Upgrade |
Short-Term Debt Issued | - | 257 | - | - | 145 | 320 | Upgrade |
Long-Term Debt Issued | - | 700 | 944 | 400 | - | 392 | Upgrade |
Total Debt Issued | - | 957 | 944 | 400 | 145 | 712 | Upgrade |
Short-Term Debt Repaid | - | - | -147 | -35 | - | - | Upgrade |
Long-Term Debt Repaid | - | -463 | -468 | -351 | -273 | -448 | Upgrade |
Total Debt Repaid | - | -463 | -615 | -386 | -273 | -448 | Upgrade |
Net Debt Issued (Repaid) | - | 494 | 329 | 14 | -128 | 264 | Upgrade |
Repurchase of Common Stock | - | -443 | -463 | -460 | -136 | -116 | Upgrade |
Dividends Paid | - | -63 | -58 | -43 | -44 | -31 | Upgrade |
Other Financing Activities | - | -3 | -3 | -3 | -3 | -2 | Upgrade |
Financing Cash Flow | - | -15 | -195 | -492 | -311 | 115 | Upgrade |
Foreign Exchange Rate Adjustments | - | 1 | 4 | 6 | 3 | 2 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | -2 | 1 | -1 | - | - | Upgrade |
Net Cash Flow | - | -293 | 334 | -500 | 248 | 464 | Upgrade |
Free Cash Flow | - | -305 | 459 | -22 | 598 | 373 | Upgrade |
Free Cash Flow Growth | - | - | - | - | 60.32% | 44.57% | Upgrade |
Free Cash Flow Margin | - | -4.21% | 6.27% | -0.30% | 8.43% | 5.91% | Upgrade |
Free Cash Flow Per Share | - | -17.47 | 24.14 | -1.06 | 27.47 | 16.67 | Upgrade |
Cash Interest Paid | - | 21 | 14 | 8 | 10 | 13 | Upgrade |
Cash Income Tax Paid | - | 257 | 221 | 557 | 465 | 122 | Upgrade |
Levered Free Cash Flow | - | -1,164 | -1,582 | -250.75 | 191.63 | -387.5 | Upgrade |
Unlevered Free Cash Flow | - | -1,151 | -1,570 | -243.88 | 198.5 | -376.25 | Upgrade |
Change in Net Working Capital | 1,307 | 1,647 | 2,327 | 1,169 | 749 | 936 | Upgrade |
Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.